The Bushido Capital US Equity ETF (SMRI) seeks to provide exposure to U.S. equity markets through an actively managed approach. As a newly launched fund from 2023, specific index tracking details are limited, but it focuses on domestic stock investments with a strategic selection methodology.
How It Works
SMRI employs an active management strategy to select U.S. equities based on proprietary research and analysis. The fund's approach differs from passive index tracking, allowing portfolio managers discretion in security selection and weighting. Given its recent inception in September 2023, the fund is still establishing its investment patterns and rebalancing methodology. Holdings composition and concentration levels are developing as the fund builds its portfolio.
Key Features
- Zero expense ratio provides cost-free access to actively managed U.S. equity exposure, eliminating annual management fees entirely
- Recently launched in September 2023, offering investors early access to Bushido Capital's proprietary investment methodology
- Active management approach allows tactical positioning and security selection beyond traditional index constraints
Risks
- This ETF can lose value due to active management decisions that may underperform market benchmarks, especially during the fund's early operational period
- New fund risk exists as SMRI lacks performance history, making it difficult to assess management effectiveness or strategy consistency over market cycles
- U.S. equity market volatility can cause significant value fluctuations, potentially declining 20-40% during broad market downturns affecting domestic stocks
Who Should Own This
Best suited for investors with medium-to-high risk tolerance seeking active U.S. equity management with zero fees, willing to accept new fund uncertainty. Appropriate as a satellite holding (5-15% allocation) for those wanting tactical exposure beyond passive indexing. Requires 3+ year time horizon to evaluate management effectiveness.